Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03792659 · ClinicalTrials.gov registry record
The EXPLORE MG Registry for Myasthenia Gravis
A clinical trial of Myasthenia Gravis, sponsored by Yale University.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT03792659: Recruiting study of Myasthenia Gravis, sponsored by Yale University.
NCT03792659 is a study of Myasthenia Gravis that is actively recruiting participants, run by Yale University. The registered enrollment target is 800 participants, above the 166-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (382% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03792659, a study of Myasthenia Gravis, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
Primary Outcome
Successful Collection of Blood
Conditions Studied
Interventions
- OTHER Blood Sample Draw
Study Locations (1)
Connecticut
- Yale-New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2016-03-30 |
| Est. Completion | 2026-10-30 |
What NCT03792659 shows while recruiting
NCT03792659 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 166-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (382% higher).
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which Blood Sample Draw is the first listed.
NCT03792659 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03792659 about?
NCT03792659 is a clinical study titled "The EXPLORE MG Registry for Myasthenia Gravis". The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
What is the current status of trial NCT03792659?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2016-03-30. Estimated completion is 2026-10-30.
What conditions does trial NCT03792659 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
What interventions are being tested in trial NCT03792659?
The interventions under investigation include: Blood Sample Draw (OTHER).
Who is sponsoring clinical trial NCT03792659?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03792659 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03792659's enrollment target sits among peer trials
800 2nd of 32 the highest of 32 other Myasthenia Gravis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myasthenia Gravis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
- NCT03855800 · 800 participants · NA
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI